Literature DB >> 15598262

Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan.

Sayda Hassan el-Safi1, Nuha Hamid, Ahmed Omer, Ahmed Abdel-Haleem, Awad Hammad, Hussein Gad Kareem, Marleen Boelaert.   

Abstract

BACKGROUND: Leishmania-tuberculosis co-infection is not uncommon in clinical practice in East Africa, but little is known about the epidemiology of this problem at population level. A cross-sectional household survey was carried out in an active visceral leishmaniasis (VL) focus in Eastern Sudan in February 2002.
METHODS: All inhabitants of Marbata village in Atbara River Area, Gedarif State, who gave informed consent, underwent both a leishmanin skin test (LST) and a tuberculin test for infection with L. donovani and Mycobacterium tuberculosis. All subjects were clinically screened for VL and tuberculosis (TB).
RESULTS: About 66% (252 of 382) were LST-positive, 26% (100 of 382) were tuberculin-positive and 20% (77 of 382) were positive for both tests. By the age of 15, more than 60% of inhabitants were LST-positive, but <20% were tuberculin-positive. By the age of 30, these percentages increased to 100 and 50%. No association was found at the individual level between leishmanial and tuberculous infection after controlling for age.
CONCLUSION: In this community study, we found no association between the risk of infection with L. donovani and M. tuberculosis. However, the progression to active VL disease might be different in M. tuberculosis-infected than in non-infected persons and vice versa. Prospective studies are needed to document the prognosis of TB/VL co-infection.

Entities:  

Mesh:

Year:  2004        PMID: 15598262     DOI: 10.1111/j.1365-3156.2004.01337.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

1.  Coinfection of Leptomonas seymouri and Leishmania donovani in Indian leishmaniasis.

Authors:  Susmita Ghosh; Priyanka Banerjee; Avijit Sarkar; Simanti Datta; Mitali Chatterjee
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

2.  First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B.

Authors:  Md Golam Hasnain; Prakash Ghosh; Md Shadab Ibn Sharafat Sonin; James Baker; Dinesh Mondal
Journal:  Clin Case Rep       Date:  2014-09-04

Review 3.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

Review 4.  Co-infection of tuberculosis and parasitic diseases in humans: a systematic review.

Authors:  Xin-Xu Li; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2013-03-22       Impact factor: 3.876

5.  Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.

Authors:  Pradyot Bhattacharya; Smriti Ghosh; Sarfaraz Ahmad Ejazi; Mehebubar Rahaman; Krishna Pandey; Vidya Nand Ravi Das; Pradeep Das; Rama Prosad Goswami; Bibhuti Saha; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2016-02-01

6.  The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis.

Authors:  Stephen Patterson; Susan Wyllie; Suzanne Norval; Laste Stojanovski; Frederick Rc Simeons; Jennifer L Auer; Maria Osuna-Cabello; Kevin D Read; Alan H Fairlamb
Journal:  Elife       Date:  2016-05-24       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.